Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin

Overview of attention for article published in Vascular Health and Risk Management, April 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 68 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Pharmaceutical compositions

Grant US-11564886-B2

United States of America

TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN

Application EP-3646859-A1

European Patent Office

PHARMACEUTICAL COMPOSITION COMPRISNG A SGLT2 INHIBITOR, A DPP-IV INHIBITOR AND OPTIONALLY…

Grant EP-2395983-B1

European Patent Office